MUMBAI, India, Aug. 10 -- Intellectual Property India has published a patent application (202617004529 A) filed by Progenics Pharmaceuticals, Inc; and Robinson, Simon, P. on January 16, 2026, for Improved Synthesis Of The Prostate Specific Membrane Antigen (psma) Radiolabeled Inhibitor [18f]dcfpyl.
Inventors include Robinson, Simon, P.; Benites, Pedro; and Siegler, Robert, W..
The application for the patent was published on July 31, 2026, under issue no. 31/2026.
Abstract: Provided herein are methods and related compositions, including kits, for the improved synthesis, preparation and/or storage of [18F]DCFPyL. Also provided are methods of using [18F]DCFPyL, such as for imaging.
Disclaimer: Curated by HT Syndication.
